Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis

Haemophilia

Volumn 21, Issue 1, 2015, Pages 81-87

  James, A H ^a   Konkle, B A ^b,c   Kouides, P ^d   Ragni, M V ^e,f   Thames, B ^a   Gupta, S ^g   Sood, S ^h   Fletcher, S K ⁱ   Philipp, C S ^j  

^a DUKE UNIVERSITY   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ROCHESTER GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f Hemophilia Center of Western Pennsylvania   (United States)

^g INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ Rutgers Robert Wood Johnson Medical School ^*  (United States)

^j ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

more..

Author keywords

Factor VIII; Postpartum haemorrhage; Pregnancy; Von Willebrand disease; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CHILDBIRTH; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; OBSERVATIONAL STUDY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PUERPERIUM; THIRD TRIMESTER PREGNANCY; TREATMENT DURATION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; METABOLISM; PREGNANCY;

ADULT; COHORT STUDIES; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84921450684     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12568     Document Type: Article

References (12)

1. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 5: 1165-9.
2. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008; 115: 1265-72.
3. Shahbazi S, Moghaddam-Banaem L, Ekhtesari F, Ala FA. Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage. Blood Coagul Fibrinolysis 2012; 23: 603-7.
4. Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost 2005; 3: 246-53.
5. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 2001; 14: 381-99.
6. Sanchez-Luceros A, Meschengieser SS, Marchese C et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis 2003; 14: 647-51.
7. Wickstrom K, Edelstam G, Lowbeer CH, Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004; 64: 31-40.
8. Huq FY, Kulkarni A, Agbim EC, Riddell A, Tuddenham E, Kadir RA. Changes in the levels of factor VIII and von Willebrand factor in the puerperium. Haemophilia 2012; 18: 241-5.
9. Deng L, Bremme K, Hansson LO, Blomback M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994; 84: 941-5.
10. Caliezi C, Tsakiris DA, Behringer H, Kuhne T, Marbet GA. Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3. Haemophilia 1998; 4: 845-9.
11. Chi C, Bapir M, Lee CA, Kadir RA. Puerperal loss (lochia) in women with or without inherited bleeding disorders. Am J Obstet Gynecol 2010; 203: 56, e1-5.
12. Wyatt KM, Dimmock PW, Walker TJ, O'Brien PM. Determination of total menstrual blood loss. Fertil Steril 2001; 76: 125-31.